Exploring Lymphovenous Anastomosis for Alzheimer Disease: Addressing Brain Lymphatic Dysfunction, Feasibility, and...

Area of Science:

• Neuroscience
• Neurosurgery
• Immunology

Background:

• Alzheimer's Disease (AD) involves amyloid-beta plaques, tau tangles, and neuroinflammation.
• Brain lymphatic dysfunction is increasingly recognized as a potential factor in AD pathogenesis.
• Current treatments for AD have limitations, necessitating novel therapeutic approaches.

Purpose of the Study:

• To review the feasibility of lymphovenous anastomosis (LVA) as a novel therapeutic strategy for Alzheimer's Disease.
• To identify key anatomical targets and patient selection criteria for LVA in the context of AD.
• To discuss outcome measures and controversies surrounding LVA for AD treatment.

Main Methods:

• Literature review evaluating the role of lymphatic dysfunction in AD.
• Analysis of LVA as a microsurgical technique for enhancing metabolite clearance.
• Assessment of preliminary studies and anatomical considerations for LVA targeting cervical lymphatic vessels.

Main Results:

• LVA offers a potential mechanism to bypass impaired lymphatic pathways and enhance glymphatic outflow.
• The technique may compensate for age-related declines in brain clearance mechanisms.
• Preliminary evidence suggests LVA's potential, but further research is required.

Conclusions:

• LVA presents a promising, novel therapeutic strategy for Alzheimer's Disease.
• Optimization of surgical protocols, clarification of biological mechanisms, and safety assessments are crucial.
• LVA could complement existing AD treatments, offering new hope for patients.